Aug 6, 2026 06:45AM
Aug 6, 2026 06:45AM
Aug 4, 2026 06:30AM
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure
Jul 17, 2026 07:07AM
Jul 16, 2026 06:45AM
Jul 16, 2026 06:45AM
Jul 15, 2026 07:00AM
Jul 15, 2026 07:00AM
Jul 15, 2026 06:45AM
Jul 15, 2026 06:45AM KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR)
Jul 10, 2026 02:10PM
Jul 10, 2026 02:10PM
Jul 8, 2026 08:00AM
Jul 8, 2026 08:00AM
Jun 29, 2026 06:45AM
Jun 29, 2026 06:45AM
Jun 25, 2026 06:45AM FDA approves Merck's Keytruda combo with Trodelvy for TNBC
Jun 25, 2026 06:45AM
Jun 24, 2026 08:30AM
Jun 24, 2026 08:30AM
Jun 24, 2026 06:45AM
Jun 24, 2026 06:45AM
Jun 18, 2026 06:45AM
Jun 18, 2026 06:45AM U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
Jun 12, 2026 04:10PM
Jun 12, 2026 04:10PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:30PM
Jun 8, 2026 04:30PM
Jun 3, 2026 09:00AM Apotex launches sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, eligible for 180-day shared exclusivity
May 29, 2026 06:49AM
May 29, 2026 06:45AM
May 22, 2026 07:55AM
May 22, 2026 07:55AM
May 13, 2026 08:30AM
May 12, 2026 06:45AM
May 12, 2026 06:45AM Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026
May 7, 2026 08:00AM
May 5, 2026 08:45AM
May 5, 2026 08:45AM
Apr 30, 2026 06:30AM
Apr 21, 2026 02:11PM
Apr 21, 2026 02:11PM
Apr 21, 2026 08:37AM Merck and Eisai report failed kidney cancer drug trial results
Apr 21, 2026 06:45AM

328,101 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All